Market Cap 378.19M
Revenue (ttm) 0.00
Net Income (ttm) -66.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 4,477,700
Avg Vol 8,945,780
Day's Range N/A - N/A
Shares Out 180.09M
Stochastic %K 42%
Beta 0.89
Analysts Strong Sell
Price Target $10.42

Company Profile

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 500 8099
Address:
80 Guest Street, Suite 601, Boston, United States
Heliosphere
Heliosphere Jun. 4 at 11:34 PM
$CMPX https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/guest_book?session_id=exgVrMDzyStggLaCGnzNeG
0 · Reply
isthisonebetter
isthisonebetter Jun. 4 at 8:12 PM
$CMPX 🥱
0 · Reply
WALLC
WALLC Jun. 4 at 4:15 PM
0 · Reply
Brandonswest
Brandonswest Jun. 4 at 3:26 PM
$CMPX volume has definitely picked up.
0 · Reply
CheGuev
CheGuev Jun. 4 at 2:02 PM
$CMPX Low volume right now but this biotech is coiled. Any positive trial data or FDA update and this thing rips. Thin tape + catalyst = moon recipe. Hang tight until 🚀 NFA.
0 · Reply
Brandonswest
Brandonswest Jun. 4 at 1:59 PM
$CMPX ok have we traded the entire float at this level? Lets go.
0 · Reply
AlwaysForAuroraHope
AlwaysForAuroraHope Jun. 4 at 12:59 PM
$CMPX Wow. What I am hearing is there is likely something to the combination of Tovecimig & Paclitaxil. Not trying to delve to deep in to theories but Paclitaxil is a Bristol Myers Squib medication. Hmmmmm.
1 · Reply
TBROS1898
TBROS1898 Jun. 4 at 11:24 AM
$CMPX da fuq? Last couple days been brutal
1 · Reply
Brandonswest
Brandonswest Jun. 4 at 11:02 AM
$CMPX looks like they're going to play the Jeffries presentation on ST. Cool but I'll be headed to work. Anybody going to have a chance to listen?
2 · Reply
Brandonswest
Brandonswest Jun. 3 at 8:03 PM
$CMPX green close is cool.
0 · Reply
Latest News on CMPX
Compass Therapeutics reports Q1 EPS (10c), consensus (10c)

2026-05-05T12:13:40.000Z - 4 weeks ago

Compass Therapeutics reports Q1 EPS (10c), consensus (10c)


Compass Therapeutics Earnings release: Q1 2026

May 5, 2026, 7:30 AM EDT - 4 weeks ago

Compass Therapeutics Earnings release: Q1 2026


Compass Therapeutics Quarterly report: Q1 2026

May 5, 2026, 7:30 AM EDT - 4 weeks ago

Compass Therapeutics Quarterly report: Q1 2026


Compass Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

Compass Therapeutics Proxy statement: Proxy filing


Compass Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

Compass Therapeutics Proxy statement: Proxy filing


Compass Therapeutics Transcript: Study update

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

Compass Therapeutics Transcript: Study update


Compass Therapeutics Press release: Study update

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

Compass Therapeutics Press release: Study update


Compass Therapeutics Slides: Study update

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

Compass Therapeutics Slides: Study update


Compass Therapeutics reports Q4 EPS (9c), consensus (9c)

2026-03-05T12:38:02.000Z - 3 months ago

Compass Therapeutics reports Q4 EPS (9c), consensus (9c)


Compass Therapeutics Earnings release: Q4 2025

Mar 5, 2026, 7:30 AM EST - 3 months ago

Compass Therapeutics Earnings release: Q4 2025


Compass Therapeutics Annual report: Q4 2025

Mar 5, 2026, 7:30 AM EST - 3 months ago

Compass Therapeutics Annual report: Q4 2025


Compass Therapeutics Annual report: Q4 2025

Mar 5, 2026, 7:30 AM EST - 3 months ago

Compass Therapeutics Annual report: Q4 2025


Compass Therapeutics Slides: Corporate presentation

Mar 5, 2026, 7:00 AM EST - 3 months ago

Compass Therapeutics Slides: Corporate presentation


Compass Therapeutics initiated with a Buy at Craig-Hallum

2026-02-13T13:15:26.000Z - 3 months ago

Compass Therapeutics initiated with a Buy at Craig-Hallum


Compass Therapeutics Slides: Corporate presentation

Jan 7, 2026, 7:00 AM EST - 5 months ago

Compass Therapeutics Slides: Corporate presentation


Compass Therapeutics provides corporate update

2026-01-06T13:36:59.000Z - 5 months ago

Compass Therapeutics provides corporate update


Compass Therapeutics Provides Corporate Update

Jan 6, 2026, 8:00 AM EST - 5 months ago

Compass Therapeutics Provides Corporate Update


Compass Therapeutics Announces Key Leadership Appointments

Jan 5, 2026, 8:00 AM EST - 5 months ago

Compass Therapeutics Announces Key Leadership Appointments


Compass Therapeutics files $400M mixed securities shelf

2025-12-30T21:10:54.000Z - 5 months ago

Compass Therapeutics files $400M mixed securities shelf


Compass Therapeutics Registration statement: Registration Filing

Dec 30, 2025, 7:00 AM EST - 5 months ago

Compass Therapeutics Registration statement: Registration Filing


Compass Therapeutics Slides: Corporate Presentation

Nov 9, 2025, 6:00 PM EST - 7 months ago

Compass Therapeutics Slides: Corporate Presentation


Compass Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 4:00 PM EST - 7 months ago

Compass Therapeutics Earnings release: Q3 2025


Compass Therapeutics Quarterly report: Q3 2025

Nov 5, 2025, 4:00 PM EST - 7 months ago

Compass Therapeutics Quarterly report: Q3 2025


Compass Therapeutics Announces Proposed Public Offering

Aug 12, 2025, 4:01 PM EDT - 10 months ago

Compass Therapeutics Announces Proposed Public Offering


Compass Therapeutics Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

Compass Therapeutics Earnings Call Transcript: Q2 2025


Compass Therapeutics Quarterly report: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

Compass Therapeutics Quarterly report: Q2 2025


Compass Therapeutics Earnings release: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

Compass Therapeutics Earnings release: Q2 2025


Compass Therapeutics Slides: Corporate Presentation

Aug 11, 2025, 7:00 AM EDT - 10 months ago

Compass Therapeutics Slides: Corporate Presentation


Compass Therapeutics Slides: Investor Presentation

Jun 5, 2025, 7:00 AM EDT - 1 year ago

Compass Therapeutics Slides: Investor Presentation


Compass Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Compass Therapeutics Earnings release: Q1 2025


Compass Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Compass Therapeutics Quarterly report: Q1 2025


Compass Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Compass Therapeutics Proxy statement: Proxy Filing


Compass Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Compass Therapeutics Proxy statement: Proxy Filing


Compass Therapeutics Transcript: Study Update

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Compass Therapeutics Transcript: Study Update


Compass Therapeutics Slides: Study Update

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Compass Therapeutics Slides: Study Update


Compass Therapeutics Annual report: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Compass Therapeutics Annual report: Q4 2024


Compass Therapeutics Earnings release: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Compass Therapeutics Earnings release: Q4 2024


Compass Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Compass Therapeutics Quarterly report: Q3 2024


Compass Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Compass Therapeutics Earnings release: Q3 2024


Compass Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Compass Therapeutics Quarterly report: Q2 2024


Compass Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Compass Therapeutics Earnings release: Q2 2024


Compass Therapeutics Slides: Corporate Presentation

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Compass Therapeutics Slides: Corporate Presentation


Compass Therapeutics Proxy statement: Proxy Filing

May 29, 2024, 8:00 AM EDT - 2 years ago

Compass Therapeutics Proxy statement: Proxy Filing


Compass Therapeutics Announces CEO Transition

May 28, 2024, 4:10 PM EDT - 2 years ago

Compass Therapeutics Announces CEO Transition


Compass Therapeutics Quarterly report: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Compass Therapeutics Quarterly report: Q1 2024


Compass Therapeutics Earnings release: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Compass Therapeutics Earnings release: Q1 2024


Compass Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Compass Therapeutics Proxy statement: Proxy Filing


Compass Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Compass Therapeutics Proxy statement: Proxy Filing


Compass Therapeutics Earnings release: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Compass Therapeutics Earnings release: Q4 2023


Compass Therapeutics Annual report: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Compass Therapeutics Annual report: Q4 2023


Compass Therapeutics Quarterly report: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Compass Therapeutics Quarterly report: Q3 2023


Compass Therapeutics Earnings release: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Compass Therapeutics Earnings release: Q3 2023


Compass Therapeutics Quarterly report: Q2 2023

Aug 3, 2023, 7:00 AM EDT - 3 years ago

Compass Therapeutics Quarterly report: Q2 2023


Compass Therapeutics Earnings release: Q2 2023

Aug 3, 2023, 7:00 AM EDT - 3 years ago

Compass Therapeutics Earnings release: Q2 2023


Heliosphere
Heliosphere Jun. 4 at 11:34 PM
$CMPX https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/guest_book?session_id=exgVrMDzyStggLaCGnzNeG
0 · Reply
isthisonebetter
isthisonebetter Jun. 4 at 8:12 PM
$CMPX 🥱
0 · Reply
WALLC
WALLC Jun. 4 at 4:15 PM
0 · Reply
Brandonswest
Brandonswest Jun. 4 at 3:26 PM
$CMPX volume has definitely picked up.
0 · Reply
CheGuev
CheGuev Jun. 4 at 2:02 PM
$CMPX Low volume right now but this biotech is coiled. Any positive trial data or FDA update and this thing rips. Thin tape + catalyst = moon recipe. Hang tight until 🚀 NFA.
0 · Reply
Brandonswest
Brandonswest Jun. 4 at 1:59 PM
$CMPX ok have we traded the entire float at this level? Lets go.
0 · Reply
AlwaysForAuroraHope
AlwaysForAuroraHope Jun. 4 at 12:59 PM
$CMPX Wow. What I am hearing is there is likely something to the combination of Tovecimig & Paclitaxil. Not trying to delve to deep in to theories but Paclitaxil is a Bristol Myers Squib medication. Hmmmmm.
1 · Reply
TBROS1898
TBROS1898 Jun. 4 at 11:24 AM
$CMPX da fuq? Last couple days been brutal
1 · Reply
Brandonswest
Brandonswest Jun. 4 at 11:02 AM
$CMPX looks like they're going to play the Jeffries presentation on ST. Cool but I'll be headed to work. Anybody going to have a chance to listen?
2 · Reply
Brandonswest
Brandonswest Jun. 3 at 8:03 PM
$CMPX green close is cool.
0 · Reply
DwigtMcDichael
DwigtMcDichael Jun. 3 at 2:39 PM
$CMPX I’m in
0 · Reply
Brandonswest
Brandonswest Jun. 3 at 2:37 PM
$CMPX maybe an early BO offer? It's been happening these last few months quite a bit.
0 · Reply
Brandonswest
Brandonswest Jun. 3 at 2:36 PM
$CMPX and here's a sampling of the folks speaking at the Goldman Sachs conference where $CMPX is also speaking: Robert M. Davis, Chairman and CEO of Merck (along with Dr. Dean Y. Li, President of Merck Research Laboratories), scheduled for a fireside chat on June 9. Richard Francis, President and CEO of Teva Pharmaceutical Industries, participating in a fireside chat on June 8. Chris Simon, President and CEO of Haemonetics, scheduled for a fireside chat on June 8. Chirag Patel, Co-CEO and President of Amneal Pharmaceuticals, presenting on June 9. John Wiggins, VP of External Manufacturing at Lantheus, participating in a fireside chat on June 9. Executives from AbbVie, Zimmer Biomet, and Bioventus are also scheduled to present or participate in fireside chats throughout the event. These sessions serve as the primary content of the conference, where industry leaders discuss their company strategies, pipelines, and market outlooks.
1 · Reply
Brandonswest
Brandonswest Jun. 3 at 1:37 PM
$CMPX to be clear The Jefferies Global Healthcare Conference is Europe’s largest dedicated healthcare investment conference, organized by Jefferies Financial Group to connect senior executives, institutional investors, private equity firms, and venture capitalists. It serves as a premier platform for addressing near- and long-term investment opportunities and discussing trends driving the healthcare sector in the U.S. and internationally. Attendance is by invitation only, requiring pre-registration through a Jefferies representative. The events facilitate high-value introductions, deal-making, and networking across the biotechnology, pharmaceutical, medical technology, and healthcare services sectors.
0 · Reply
Heliosphere
Heliosphere Jun. 3 at 1:21 PM
$CMPX Jefferies Global Healthcare Conference Date: Thursday, June 4, 2026 Time: 8:45 AM ET Webcast Link: https://cmpx.info/jefferies
1 · Reply
Norton850
Norton850 Jun. 3 at 1:27 AM
$CMPX June opex max pain is $2.00.
0 · Reply
Norton850
Norton850 Jun. 2 at 11:25 PM
$CMPX $OMER Leadership vacuums, high level departures and uncertainty at the FDA are weighing the biotech sector down.
0 · Reply
Norton850
Norton850 Jun. 2 at 7:47 PM
$CMPX If it revisits my avg $1.84 I'm buying more.
1 · Reply
Lexcol
Lexcol Jun. 2 at 7:44 PM
$CMPX Waiting merger With Regeneron $REGN
0 · Reply
Cristianoo
Cristianoo Jun. 2 at 7:26 PM
$CMPX It’s a biotech stock if you can’t handle the waves then get off the boat 😤
0 · Reply
drewb504
drewb504 Jun. 2 at 4:45 PM
$CMPX 2.11 the new bottom… 🤨😬🤷🏻‍♂️
0 · Reply
guidoschini
guidoschini Jun. 2 at 3:46 PM
$CMPX he practically almost lost the $2 as well
0 · Reply